GOLDENWELL BIOTECH, INC. - 10-Q Filing
Goldenwell Biotech reports Q3 2026 net loss of $31,540 and a significant decline in cash reserves to $788.
Tickers: $GWLL
Read the full article at SEC EDGAR
Part of the story SUPA Consolidated Inc. - 10-Q Filing (2 articles)